Publication: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Su, Y., T. M. Blazey, C. J. Owen, J. J. Christensen, K. Friedrichsen, N. Joseph-Mathurin, Q. Wang, et al. 2016. “Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group.” PLoS ONE 11 (3): e0152082. doi:10.1371/journal.pone.0152082. http://dx.doi.org/10.1371/journal.pone.0152082.
Research Data
Abstract
Amyloid imaging plays an important role in the research and diagnosis of dementing disorders. Substantial variation in quantitative methods to measure brain amyloid burden exists in the field. The aim of this work is to investigate the impact of methodological variations to the quantification of amyloid burden using data from the Dominantly Inherited Alzheimer’s Network (DIAN), an autosomal dominant Alzheimer’s disease population. Cross-sectional and longitudinal [11C]-Pittsburgh Compound B (PiB) PET imaging data from the DIAN study were analyzed. Four candidate reference regions were investigated for estimation of brain amyloid burden. A regional spread function based technique was also investigated for the correction of partial volume effects. Cerebellar cortex, brain-stem, and white matter regions all had stable tracer retention during the course of disease. Partial volume correction consistently improves sensitivity to group differences and longitudinal changes over time. White matter referencing improved statistical power in the detecting longitudinal changes in relative tracer retention; however, the reason for this improvement is unclear and requires further investigation. Full dynamic acquisition and kinetic modeling improved statistical power although it may add cost and time. Several technical variations to amyloid burden quantification were examined in this study. Partial volume correction emerged as the strategy that most consistently improved statistical power for the detection of both longitudinal changes and across-group differences. For the autosomal dominant Alzheimer’s disease population with PiB imaging, utilizing brainstem as a reference region with partial volume correction may be optimal for current interventional trials. Further investigation of technical issues in quantitative amyloid imaging in different study populations using different amyloid imaging tracers is warranted.
Description
Other Available Sources
Keywords
Biology and Life Sciences, Anatomy, Nervous System, Central Nervous System, Medicine and Health Sciences, Physical Sciences, Chemistry, Polymer Chemistry, Macromolecules, Polymers, Polyvinyl Chloride, Materials Science, Materials by Structure, Brain, Cerebellar Cortex, Brainstem, Mental Health and Psychiatry, Dementia, Alzheimer Disease, Neurology, Neurodegenerative Diseases, Imaging Techniques, Neuroimaging, Positron Emission Tomography, Neuroscience, Diagnostic Medicine, Diagnostic Radiology, Tomography, Radiology and Imaging, Science Policy, Genetics, Gene Identification and Analysis, Mutation Detection
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service